Market Exclusive

Analyst Activity – Credit Suisse Group Reiterates Outperform on Allergan PLC. (NYSE:AGN)

Analyst Ratings For Allergan PLC. (NYSE:AGN)

Today, Credit Suisse Group reiterated its Outperform rating on Allergan PLC. (NYSE:AGN) with a price target of $266.00.

There are 6 hold ratings, 12 buy ratings on the stock.

The current consensus rating on Allergan PLC. (NYSE:AGN) is Buy (Score: 2.67) with a consensus target price of $273.47 per share, a potential 33.63% upside.

Some recent analyst ratings include

Dividend information for Allergan PLC. (NYSE:AGN)

Allergan PLC. (NYSE:AGN) pays an annual dividend of Community Ranking: with a yield of 1.37% and an average dividend growth of 0.00% based on a 3 Year Average.

Dividend History for Allergan PLC. (NYSE:AGN)

Recent Insider Trading Activity For Allergan PLC. (NYSE:AGN)
Allergan PLC. (NYSE:AGN) has insider ownership of 0.36% and institutional ownership of 82.02%.

Recent Trading Activity for Allergan PLC. (NYSE:AGN)
Shares of Allergan PLC. closed the previous trading session at with shares trading hands.

Exit mobile version